Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluation of Glomerular Hemodynamic Function by Empagliflozin in Diabetic Mice Using In Vivo Imaging

Published:2019-07-23 Issue:4 Volume:140 Page:303-315
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Kidokoro Kengo¹,Cherney David Z.I.²,Bozovic Andrea³,Nagasu Hajime¹,Satoh Minoru¹,Kanda Eiichiro¹,Sasaki Tamaki¹,Kashihara Naoki¹

Affiliation:

1. Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Okayama, Japan (K.K., H.N., M.S., E.K., T.S., N.K.).

2. Division of Nephrology, Department of Medicine (D.Z.I.C.), University Health Network, University of Toronto, Canada.

3. Department of Laboratory Medicine and Pathology (A.B.), University Health Network, University of Toronto, Canada.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference50 articles.

1. Sodium Glucose Cotransporter-2 Inhibition in Heart Failure

2. Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus

3. Chronic Kidney Disease in Diabetes

4. Managing the Course of Kidney Disease in Adults With Type 2 Diabetes: From the Old to the New

5. Modeling oxygen consumption in the proximal tubule: effects of NHE and SGLT2 inhibition

Cited by 220 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mechanisms of heart failure and chronic kidney disease protection by SGLT2 inhibitors in nondiabetic conditions;American Journal of Physiology-Cell Physiology;2024-09-01

2. Impact of age on eGFR dynamics following sodium-glucose cotransporter 2 inhibitor therapy: A real-world study;Diabetes Research and Clinical Practice;2024-08

3. Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials;The Lancet Diabetes & Endocrinology;2024-08

4. The Renoprotective Mechanisms of Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2i)—A Narrative Review;International Journal of Molecular Sciences;2024-06-27

5. Effects of Empagliflozin in Type 2 Diabetes With and Without Chronic Kidney Disease and Nondiabetic Chronic Kidney Disease: Protocol for 3 Crossover Randomized Controlled Trials (SiRENA Project);JMIR Research Protocols;2024-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3